FUSED BICYCLIC COMPOUNDS AND THEIR USE AS MER AND AXL INHIBITORS

1H-CYCLOPENTA[B]BENZOFURAN DERIVATIVES FOR THE PREVENTION AND TREATMENT OF VIRUS DISEASES

BROMINE- OR IODINE-PARA-SUBSTITUTED [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND THEIR SALTS, AGENTS FOR PROTECTING USEFUL PLANTS OR CROP PLANTS COMPRISING THEM, METHODS FOR PRODUCING THEM AND THEIR USE AS SAFENERS

MODULATORS OF THE CALCIUM SIGNALING CASCADE

WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE

QUINAZOLINE DERIVATIVE COMPOUND AND USE THEREOF

BAX INHIBITORS AND USES THEREOF

IMIDAZOLE DERIVATIVES

ABAD INHIBITOR COMPOUNDS

Alkylphenyl Substituted Compounds, Compositions and Methods of Use

Amino Pyrimidine Derivatives

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

METHODS FOR TREATING CANCER

HIPK4 Degraders as Non-Hormonal Male Contraceptives

IRREVERSIBLE INACTIVATORS TARGETING ARAF/MEK COMPLEXES

CANCER TREATMENTS TARGETING CANCER STEM CELLS

HETEROARYL COMPOUNDS AS MULTI-TARGET PROTEIN KINASE INHIBITORS

LACTATE ENHANCING COMPOUNDS AND USES THEREOF

Isoquinolinone Derivatives and 4H-Quinolizinone Derivatives and Pharmaceutical Compositions Thereof for the Treatment of Disease

STAPHYLOCOCCUS AUREUS PBP4 INHIBITORS AND METHOD OF USE

CYCLOPENTANE COMPOUND

APYRASE INHIBITORS

MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES

2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS

PROCESS FOR MANUFACTURING ALOGABAT

CHEMICAL INHIBITION OF THE E3 LIGASE SUBUNIT FBXO7 CONFERS NEUROPROTECTION AND ANTI-INFLAMMATORY ACTIVITY BY STABILIZING MITOCHONDRIA

COMPOUNDS, DEVICES, AND USES THEREOF

HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER

LIGHT-RECEIVING DEVICE AND LIGHT-EMITTING AND LIGHT-RECEIVING APPARATUS

8-HYDROXYQUINOLINE COMPOUND AND USE THEREOF

SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY

IMMUNOSUPPRESSIVE COMPOUNDS

METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION

Small molecule inhibitors of the ribosome biogenesis factor NVL2

PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS

Tetrahydroquinoline Compounds As Antitumor Agents

CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF

INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

COMPOSITIONS AND METHODS FOR TREATING CANCER

SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF

BENZOFURAN DERIVATIVES AS SIK INHIBITORS AND THE USE THEREOF

TRIPLE KINASE INHIBITORS

ACSS2 INHIBITORS AND METHODS OF USE THEREOF

COMPOUND USED AS INHIBITOR OF CDK4 KINASE AND USE THEREOF

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

SOLID FORMS OF A ROCK INHIBITOR

ANTI-VIRAL COMPOUNDS

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

TPK AGONIST AND METHOD FOR USING SAME TO TREAT NEURODEGENERATIVE DISEASES

BICYCLONONYNE REAGENTS FOR CELL IMAGING

HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS

AMIDE OR UREA COMPOUND

Inhibitors of Dihydroceramide Desaturase for Treating Disease

TNKS2 INHIBITORS

BENZOYLFORMIC ACID AMIDE DERIVATIVE

NOVEL EQUILIBRATIVE NUCLEOSIDE TRANSPORTER INHIBITORS AND METHODS OF MAKING AND USING SAME

ORGANIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME

ORGANIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME

NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME

SUBSTITUTED PYRIDONE GPR84 ANTAGONISTS AND USES THEREOF

HETEROCYCLIC COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL USE THEREOF

APOL1 INHIBITORS AND METHODS OF USE

HETEROCYCLIC INHIBITORS OF MCT4

ANTIBACTERIAL COMPOUNDS

Substituted Tetrazolyl Compounds Useful as T Cell Activators

SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS

TETRAHYDROISOQUINOLINYLMETHYLBENZAMIDE COMPOUNDS

PI3K-ALPHA INHIBITORS FOR THE TREATMENT OF CANCER

NOVEL SULFONES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

2(1H)-PYRIDINIMINE DERATIVE

SUBSTITUTED BENZIMIDAZOLES FOR TREATING VIRAL DISEASES

INHIBITION OF GLIAL CELL ACTIVATION

PHENYL-N-QUINOLINE DERIVATIVES FOR TREATING A RNA VIRUS INFECTION

N-PHENYL-1-(PHENYLSULFONYL)PIPERIDIN-4-AMINE DERIVATIVES AS CCR6 INHIBITORS

N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER

PRMT5 INHIBITORS AND USES THEREOF

NOVEL NAPHTHYL AND ISOQUINOLINE SULFONAMIDE DERIVATIVES

Functional Layer Material, Light-Emitting Device, and Display Panel

NAV1.8 INHIBITOR

BULLEYACONITINE A DERIVATIVE WITH ANALGESIC ACTIVITY, AND PREPARATION METHOD AND APPLICATION THEREOF

N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION

PI3K INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

ACYLSULFONAMIDE KAT6A INHIBITORS

ALKOXY HETEROARYL- CARBOXAMIDE OR THIOAMIDE COMPOUNDS

CHEMICAL COMPOUNDS AND USES THEREOF

EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF

QUINOLINONE AMIDE COMPOUNDS AND USES THEREOF

PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

N-SUBSTITUTED DERIVATIVES OF L-(L-PHENYL-3-ARYL)-LFF-PYRAZOL-4-YL)METHANAININE, METHOD FOR THEIR PRODUCTION AND THEIR APPLICATIONS

TRIAZOLE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR D

ANTIBACTERIAL COMPOUNDS

COMPOUND CONTAINING SULFAMIDE STRUCTURE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITION AND APPLICATION

SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS

SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF

NANOMATERIALS

PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS

CANNALACTONE ANALOGS, SYNTHESIS AND USE FOR STIMULATION OF GERMINATION OF PARASITIC PLANT SEEDS

SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS

AMP-ACTIVATED PROTEIN KINASE MODULATOR COMPOUNDS AND USES THEREOF

NLRP3 INHIBITORS

ESTROGEN RECEPTOR ALPHA DEGRADERS AND METHODS OF USE THEREOF

AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS

3-ALKYNYL CARBOXAMIDES AS AEP MODULATORS

POLYSUBSTITUTED BENZENE COMPOUND AND PREPARATION METHOD AND USE THEREOF

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S AND GAUCHER DISEASE

CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON’S DISEASE

INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS

METHODS FOR INHIBITING FASCIN

PHENYL AMIDE COMPOUNDS AND METHODS OF USE

FLAVONOID COMPOUNDS AND METHODS AND MATERIALS FOR USING FLAVONOID COMPOUNDS TO TREAT FIBROTIC CONDITIONS

QUINOLINEAMINE ANTIDEGRADANT COMPOUNDS AND USES THEREOF

Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof

NOVEL MOLECULES

MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88

ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS

1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF

CSF-1R INHIBITORS AND USES THEREOF

N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS

N-TETRAZOLYL ARYL UREA-BASED DERIVATIVES, PREPARATION METHOD THEREFOR, AND USE THEREOF

PROCESS FOR THE SYNTHESIS OF SUBSTITUTED TETRAHYDROFURAN MODULATORS OF SODIUM CHANNELS

BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF

CANNABICYCLOL DERIVATIVES AND PREPARATION METHODS THEREOF

3-PHENYLPROPYLAMINE DERIVATIVE

INTERLUKIN-17A INHIBITORS AND USES THEREOF

SALTS OF C4-CARBOXYLIC ACID- AND C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING

C4-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING

DEGRADER COMPOUNDS OF QSOX1 mRNA

CHROMENE DERIVATIVES AS INHIBITORS OF TCR-NCK INTERACTION

NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS

SPLEEN TYROSINE KINASE INHIBITORS AND METHODS OF USE THEREOF

INHIBITORS OF PARG

OCT4 HIGH-SELECTIVITY ACTIVATOR

GLP-1 Receptor Agonists and Uses Thereof

GPR84 ANTAGONISTS AND USES THEREOF

COMPOUNDS AND METHODS FOR INHIBITING FASCIN

CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE

AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME

PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY

CYCLIC QUATERNARY AMMONIUM SALT COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF

PIPERAZINE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION

CHROMEN-2-ONE MODULATORS OF POLRMT

PI4-Kinase Inhibitors and Methods of Using the Same

ANTI-SARS-COV-2 DRUG

INHIBITORS OF FATTY ACID BINDING PROTEINS (FABPs), METHODS OF USE AND METHODS OF MAKING

SEROTONIN ANALOGUES FOR USE IN TREATING METALLOPTOSIS-ASSOCIATED DISORDERS

THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF

NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS

AMINOHETEROARYL KINASE INHIBITORS

SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF

COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME

SIALIC ACID DERIVATIVES AND METHODS OF USING SAME

Pharmaceutical Compounds And Compositions As Modulators Of MAS-Related G-Protein Receptor X2

NICOTINATE ESTERS AND THERAPEUTIC METHODS OF USE THEREOF

AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS

ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF

ALDH2 INHIBITORS AND METHODS OF USE THEREOF

LIGHT EMITTING ELEMENT, AMINE COMPOUND FOR THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE SAME

AROMATIC AMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS

BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF

ACID ADDITION SALTS OF BENZIMIDAZOLE DERIVATIVE

TYPE OF NOVEL LIPID COMPOUND AND USE THEREOF

KAT6 Inhibitors

ORGANIC COMPOUND AND ELECTRONIC ELEMENT AND ELECTRONIC APPARATUS COMPRISING SAME

Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase

SELECTIVE LIGANDS FOR MODULATION OF GIRK CHANNELS

BICYCLIC PIPERAZINONES AND THERAPEUTIC USES THEREOF

TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS

Methods and Compositions for Treatment of Inflammation and Inflammatory Conditions

PLPRO PROTEIN INHIBITOR, AND PREPARATION METHOD AND APPLICATION THEREOF

HETEROCYCLIC DERIVATIVES AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS

REVERSIBLE LYSINE COVALENT MODIFIERS OF CDK2 AND USES THEREOF

INDOLE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF

OREXIN RECEPTOR AGONISTS

Organic Compound And Organic Light-Emitting Diode Including Same

CARDIAC SARCOMERE INHIBITORS

ORAL COMPLEMENT FACTOR D INHIBITORS

COMPOUNDS AND METHODS OF THEIR USE

GPCR REGULATOR AND USE THEREOF

PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF

MEK INHIBITORS AND THERAPEUTIC USES THEREOF

HUMAN PLASMA KALLIKREIN INHIBITORS

SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR

COMPOUNDS, PREPARATION METHODS AND USES THEREOF

PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS

COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO

INDUCERS OF INTEGRATED STRESS RESPONSE TO TREAT CANCER

HUMAN PLASMA KALLIKREIN INHIBITORS

MCT4 INHIBITORS FOR TREATING DISEASE

1,4-Substituted Piperidine Derivatives

INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

ORGANIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE

COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF

METHODS FOR TREATING CANCER

RAF KINASE INHIBITORS AND METHODS OF USE THEREOF

NOVEL SUBSTITUTED 4-AMINO-4-OXO-BUT-2-ENYL DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF

INNATE IMMUNE-ACTIVATING DRUG AND USE THEREOF

DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS

COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS

3-BETA-HSD1 INHIBITORS AND COMPOSITIONS AND USES THEREOF

2,3-DIHYDROBENZO[B][1,4]DIOXIN-6-YL CONTAINING COMPOUNDS USEFUL AS IMMUNOMODULATORS

QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION

LIGHT-EMITTING ELEMENT, AMINE COMPOUND FOR THE LIGHT-EMITTING ELEMENT, AND DISPLAY DEVICE INCLUDING THE LIGHT-EMITTING ELEMENT

POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS

CYCLOOLEFIN SUBSTITUTED HETEROAROMATIC COMPOUNDS AND THEIR USE

SUBSTITUTED BENZAMIDES AS HERBICIDES

GPR35 MODULATORS AND USES THEREOF

COMPOUND AS KIF18A INHIBITOR

TRIAZINE DERIVATIVES FOR TREATING DISEASES RELATING TO NEUROTROPHINS

T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING AN AZASPIRONONANE CORE AND METHODS OF USE THEREOF

STAT6 INHIBITORS AND USES THEREOF

SUBSTITUTED TETRAHYDROFURAN ANALOGS AS MODULATORS OF SODIUM CHANNELS

SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS

2-[(2-OXO-4-PHENYL-2H-CHROMEN-7-YL)OXY] PROPANAMIDO DERIVATIVES

SALTS OF C4-CARBOXYLIC ACID- AND C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING

HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER

COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES

SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS

PHARMACEUTICAL INTERMEDIATE AND SYNTHESIS METHOD, AND ISOQUINOLINE DERIVATIVE AND SYNTHESIS METHOD THEREFOR

NOVEL RAS INHIBITORS

N-ACYLHYDRAZONIC COMPOUNDS, USE IN THE TREATMENT OF AMYLOID AND NON-AMYLOID DEGENERATIVE AGGREGOPATHIES, AND PHARMACEUTICAL COMPOSITION

2-OXO-DIHYDROQUINOLINE-3-CARBOXAMIDE DERIVATIVES AS GABA TYPE A RECEPTOR MODULATORS

NOVEL DIAZEPINES THAT TARGET YELLOW FEVER VIRUS NON-STRUCTURAL 4B (NS4B) PROTEIN AND THEIR METHOD OF USE

C4-CARBOXYLIC ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING

Radiolabeled Mu Opioid Antagonist and Methods of Making and Using the Same

CDK2 INHIBITOR AND PREPARATION METHOD AND USE THEREOF

ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS

LIGHT-CONTROLLED BIOORTHOGONAL TETRAZINE LIGATION

NON-AROMATIC CYCLIC-PYRIMIDINE ANALOGS AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS

TUBULIN INHIBITORS

COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES

SYSTEM AND METHOD OF WAGERING ON A PLURALITY OF EVENTS

LPAR1 ANTAGONISTS AND USES THEREOF

METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF

ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT COMPOUND FOR THE SAME

COMPOUND SERVING AS MASP-2 INHIBITOR, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF

PYRROLIDINE COMPOUNDS

ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS

ALLOSTERIC STING MODULATORS AND METHODS OF USE

METHODS OF TREATING CANCER

New Coolants, and Preparations Containing Same

METHOD FOR PRODUCING AMIDE COMPOUND

CATIONIC LIPID ANALOGUES, COMPOSITIONS AND USES THEREOF

GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE

COUMARIN COMPOUNDS AND USES THEREOF

GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF

3,4-Dihydroisoquinolin-1(2H)-Ones Derivatives as STING Antagonists and the Use Thereof

HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

MODULATORS OF THE INTEGRATED STRESS PATHWAY

DANTROLENE PRODRUGS AND METHODS OF THEIR USE

ACYLATED HETEROCYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2

FUSED HETEROCYCLIC COMPOUNDS AS PI3KALPHA INHIBITORS

PYRAZINE COMPOUNDS AS IRREVERSIBLE INHIBITORS OF FLT3

ACYLSULFONAMIDE KAT6A INHIBITORS

ANTAGONISTS OF CAV 2.3

SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

NEW QUINOLINE DERIVATIVES

PROCESS FOR PREPARING HISTONE DEMETHYLASE INHIBITORS

GLUCOSIDE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS

ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME

SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS

SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS

NOVEL INDOLE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF

METHODS AND COMPOSITIONS OF INHIBITING DCN1-UBC12 INTERACTION

SULFOXIMINE GLYCOSIDASE INHIBITORS

TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF

ROCAGLATE DERIVATIVES AND USES THEREOF

BIPHENYL-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS

PYRIDAZINE DERIVATIVES AND RELATED USES

NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE

COMPOSITION COMPRISING TETRACYCLIC COMPOUND

COMBINATION THERAPY FOR TREATING CANCER

BICYCLIC-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS

NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE

N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION

COMPOSITIONS AND METHODS FOR TREATING CANCER

ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES

SPIROCYCLIC CAV2.3 ANTAGONISTS

CDK12/13 COVALENT INHIBITORS OR PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF

MERCAPTOPYRIMIDINE COMPOUNDS THAT INHIBIT NONHOMOLOGOUS END JOINING AND METHODS THEREOF

MEK INHIBITORS AND METHODS OF THEIR USE

COMPOUND AND USE THEREOF IN ORGANIC OPTOELECTRONIC DEVICE

COMPOSITIONS AND METHODS FOR TREATING CANCER

RIPK3 INHIBITORS AND METHODS OF USE

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY

GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE

SUBSTITUTED CYCLOHEXYL COMPOUNDS AS NOP INHIBITORS

Arylamine Compound and Use thereof, Electroluminescent Device and Display Apparatus

SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF

BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS

HETEROCYCLIC SULFONAMIDE DERIVATIVES AND PHARMACEUTICAL USES THEREOF